Sponsors: []Modifications: (h)  in compliance with Section 58-85-103:(i)  obtaining an investigational drug or investigational device;(ii)  administering the investigational drug to an eligible patient; or(iii)  treating an eligible patient with the investigational drug or investigational device;or(i)(1)(a)(b)(c)(2)  "Unprofessional conduct" does not include, in compliance with Section 58-85-103:(a)  obtaining an investigational drug or investigational device;(b)  administering the investigational drug to an eligible patient; or(c)  treating an eligible patient with the investigational drug or investigational device.(h)  in compliance with Section 58-85-103:(i)  obtaining an investigational drug or investigational device;(ii)  administering the investigational drug to an eligible patient; or(iii)  treating an eligible patient with the investigational drug or investigational device;or(i)(1)(a)(b)(2)  "Unprofessional conduct" does not include, in compliance with Section 58-85-103:(a)  obtaining an investigational drug or investigational device;(b)  administering the investigational drug to an eligible patient; or(c)  treating an eligible patient with the investigational drug or investigational device.     58-85-101.This chapter is known as the "Utah Right to Try Act."     58-85-102.As used in this chapter:(1)  "Eligible patient" means an individual who has been diagnosed with a terminalillness by a physician.(2)  "Physician" means an individual who is licensed under:(a)  Title 58, Chapter 67, Utah Medical Practice Act; or(b)  Title 58, Chapter 68, Utah Osteopathic Medical Practice Act.(3)  "Insurer" means the same as that term is defined in Section 31A-1-301.(4)  "Investigational device" means a device that:(a)  meets the definition of "investigational device" in 21 C.F.R. Sec. 812.3; and(b)  has successfully completed the United States Food and Drug Administration Phase1 testing for an investigational device described in 21 C.F.R. Part 812.(5)  "Investigational drug" means a drug that:(a)  meets the definition of "investigational new drug" in 21 C.F.R. Sec. 312.3; and(b)  has successfully completed the United States Food and Drug Administration Phase1 testing for an investigational new drug described in 21 C.F.R. Part 312.(6)  "Terminal illness" means a condition of a patient that:(a)  is serious or life-threatening;(b)  as determined by a physician, is likely to pose a greater risk to the patient than therisk posed to the patient by treatment with an investigational drug or investigational device;and(c)  presents the patient with no treatment option that is satisfactory or comparable totreatment with an investigational drug or device.     58-85-103.(1)  An eligible patient may obtain an investigational drug through an agreement withthe investigational drug's manufacturer and the eligible patient's physician that provides:(a)  for the transfer of the investigational drug from the manufacturer to the physician;and(b)  that the physician will administer the investigational drug to the patient.(2)  An eligible patient may obtain an investigational device through an agreement withthe investigational device's manufacturer and the eligible patient's physician that provides:(a)  for the transfer of the investigational device from the manufacturer to the physician;and(b)  that the physician will use the investigational device to treat the patient.     58-85-104.This chapter does not:(1)  require an insurer to cover the cost of:(a)  administering an investigational drug under this chapter; or(b)  treating a patient with an investigational device under this chapter;(2)  prohibit an insurer from covering the cost of:(a)  administering an investigational drug under this chapter; or(b)  treating a patient with an investigational device under this chapter;(3)  require a manufacturer of an investigational drug or investigational device to agreeto make an investigational drug or investigational device available to an eligible patient or aneligible patient's physician;(4)  require a physician to agree to:(a)  administer an investigational drug to an eligible patient under this chapter; or(b)  treat an eligible patient with an investigational device under this chapter; or(5)  create a private right of action for any harm done to an eligible patient:(a)  resulting from the eligible patient's use of an investigational drug or investigationaldevice, against:(i)  a manufacturer of an investigational drug or investigational device under thischapter;(ii)  a physician who administers an investigational drug or treats an eligible patientwith an investigational device under this chapter; or(iii)  a hospital where a physician administers an investigational drug to an eligiblepatient or treats an eligible patient with an investigational device under this chapter;(b)  against a physician or hospital, for the physician's or hospital's refusal to:(i)  administer an investigational drug to an eligible patient under this chapter; or(ii)  treat an eligible patient with an investigational device under this chapter; or(c)  against a manufacturer, for the manufacturer's refusal to provide an eligible patientwith an investigational drug or an investigational device under this chapter.Full text:



1     INVESTIGATIONAL DRUG AND DEVICE ACCESS FOR2     TERMINALLY ILL PATIENTS3     2015 GENERAL SESSION4     STATE OF UTAH5     Chief Sponsor:  Gage Froerer6     Senate Sponsor:   Evan J. Vickers7      8     LONG TITLE9     General Description:10          This bill amends provisions related to investigational drugs and devices.11     Highlighted Provisions:12          This bill:13                provides that a terminally ill patient may obtain an investigational drug or device14     from the drug's or device's manufacturer under certain circumstances; and15                exempts certain conduct from the definition of unlawful and unprofessional conduct16     for a physician who administers an investigational drug or uses an investigational17     device to treat a terminally ill patient.18     Money Appropriated in this Bill:19          None20     Other Special Clauses:21          None22     Utah Code Sections Affected:23     AMENDS:24          58-67-501, as last amended by Laws of Utah 2001, Chapter 11625          58-67-502, as last amended by Laws of Utah 2014, Chapter 7226          58-68-501, as last amended by Laws of Utah 2001, Chapter 11627          58-68-502, as last amended by Laws of Utah 2014, Chapter 7228     ENACTS:29          58-85-101, Utah Code Annotated 195330          58-85-102, Utah Code Annotated 195331          58-85-103, Utah Code Annotated 195332          58-85-104, Utah Code Annotated 195333      34     Be it enacted by the Legislature of the state of Utah:35          Section 1.  Section 58-67-501 is amended to read:36          58-67-501. Unlawful conduct.37          (1)  "Unlawful conduct" includes, in addition to the definition in Section 58-1-501:38          (a)  buying, selling, or fraudulently obtaining, any medical diploma, license, certificate,39     or registration;40          (b)  aiding or abetting the buying, selling, or fraudulently obtaining of any medical41     diploma, license, certificate, or registration;42          (c)  substantially interfering with a licensee's lawful and competent practice of medicine43     in accordance with this chapter by:44          (i)  any person or entity that manages, owns, operates, or conducts a business having a45     direct or indirect financial interest in the licensee's professional practice; or46          (ii)  anyone other than another physician licensed under this title, who is engaged in47     direct clinical care or consultation with the licensee in accordance with the standards and ethics48     of the profession of medicine; or49          (d)  entering into a contract that limits a licensee's ability to advise the licensee's50     patients fully about treatment options or other issues that affect the health care of the licensee's51     patients.52          (2)  "Unlawful conduct" does not include:53          (a)  establishing, administering, or enforcing the provisions of a policy of accident and54     health insurance by an insurer doing business in this state in accordance with Title 31A,55     Insurance Code;56          (b)  adopting, implementing, or enforcing utilization management standards related to57     payment for a licensee's services, provided that:58          (i)  utilization management standards adopted, implemented, and enforced by the payer59     have been approved by a physician or by a committee that contains one or more physicians; and60          (ii)  the utilization management standards does not preclude a licensee from exercising61     independent professional judgment on behalf of the licensee's patients in a manner that is62     independent of payment considerations;63          (c)  developing and implementing clinical practice standards that are intended to reduce64     morbidity and mortality or developing and implementing other medical or surgical practice65     standards related to the standardization of effective health care practices, provided that:66          (i)  the practice standards and recommendations have been approved by a physician or67     by a committee that contains one or more physicians; and68          (ii)  the practice standards do not preclude a licensee from exercising independent69     professional judgment on behalf of the licensee's patients in a manner that is independent of70     payment considerations;71          (d)  requesting or recommending that a patient obtain a second opinion from a licensee;72          (e)  conducting peer review, quality evaluation, quality improvement, risk management,73     or similar activities designed to identify and address practice deficiencies with health care74     providers, health care facilities, or the delivery of health care;75          (f)  providing employment supervision or adopting employment requirements that do76     not interfere with the licensee's ability to exercise independent professional judgment on behalf77     of the licensee's patients, provided that employment requirements that may not be considered to78     interfere with an employed licensee's exercise of independent professional judgment include:79          (i)  an employment requirement that restricts the licensee's access to patients with80     whom the licensee's employer does not have a contractual relationship, either directly or81     through contracts with one or more third-party payers; or82          (ii)  providing compensation incentives that are not related to the treatment of any83     particular patient;84          (g)  providing benefit coverage information, giving advice, or expressing opinions to a85     patient or to a family member of a patient to assist the patient or family member in making a86     decision about health care that has been recommended by a licensee; [or]87          (h)  in compliance with Section 58-85-103:88          (i)  obtaining an investigational drug or investigational device;89          (ii)  administering the investigational drug to an eligible patient; or90          (iii)  treating an eligible patient with the investigational drug or investigational device;91     or92          [(h)] (i)  any otherwise lawful conduct that does not substantially interfere with the93     licensee's ability to exercise independent professional judgment on behalf of the licensee's94     patients and that does not constitute the practice of medicine as defined in this chapter.95          Section 2.  Section 58-67-502 is amended to read:96          58-67-502. Unprofessional conduct.97          (1)  "Unprofessional conduct" includes, in addition to the definition in Section98     58-1-501:99          [(1)] (a)  using or employing the services of any individual to assist a licensee in any100     manner not in accordance with the generally recognized practices, standards, or ethics of the101     profession, state law, or division rule;102          [(2)] (b)  making a material misrepresentation regarding the qualifications for licensure103     under Section 58-67-302.7; or104          [(3)] (c)  violating the dispensing requirements of Section 58-17b-309 or Chapter 17b,105     Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy,106     if applicable.107          (2)  "Unprofessional conduct" does not include, in compliance with Section 58-85-103:108          (a)  obtaining an investigational drug or investigational device;109          (b)  administering the investigational drug to an eligible patient; or110          (c)  treating an eligible patient with the investigational drug or investigational device.111          Section 3.  Section 58-68-501 is amended to read:112          58-68-501. Unlawful conduct.113          (1)  "Unlawful conduct" includes, in addition to the definition in Section 58-1-501:114          (a)  buying, selling, or fraudulently obtaining any osteopathic medical diploma, license,115     certificate, or registration; and116          (b)  aiding or abetting the buying, selling, or fraudulently obtaining of any osteopathic117     medical diploma, license, certificate, or registration;118          (c)  substantially interfering with a licensee's lawful and competent practice of medicine119     in accordance with this chapter by:120          (i)  any person or entity that manages, owns, operates, or conducts a business having a121     direct or indirect financial interest in the licensee's professional practice; or122          (ii)  anyone other than another physician licensed under this title, who is engaged in123     direct clinical care or consultation with the licensee in accordance with the standards and ethics124     of the profession of medicine; or125          (d)  entering into a contract that limits a licensee's ability to advise the licensee's126     patients fully about treatment options or other issues that affect the health care of the licensee's127     patients.128          (2)  "Unlawful conduct" does not include:129          (a)  establishing, administering, or enforcing the provisions of a policy of accident and130     health insurance by an insurer doing business in this state in accordance with Title 31A,131     Insurance Code;132          (b)  adopting, implementing, or enforcing utilization management standards related to133     payment for a licensee's services, provided that:134          (i)  utilization management standards adopted, implemented, and enforced by the payer135     have been approved by a physician or by a committee that contains one or more physicians; and136          (ii)  the utilization management standards does not preclude a licensee from exercising137     independent professional judgment on behalf of the licensee's patients in a manner that is138     independent of payment considerations;139          (c)  developing and implementing clinical practice standards that are intended to reduce140     morbidity and mortality or developing and implementing other medical or surgical practice141     standards related to the standardization of effective health care practices, provided that:142          (i)  the practice standards and recommendations have been approved by a physician or143     by a committee that contains one or more physicians; and144          (ii)  the practice standards do not preclude a licensee from exercising independent145     professional judgment on behalf of the licensee's patients in a manner that is independent of146     payment considerations;147          (d)  requesting or recommending that a patient obtain a second opinion from a licensee;148          (e)  conducting peer review, quality evaluation, quality improvement, risk management,149     or similar activities designed to identify and address practice deficiencies with health care150     providers, health care facilities, or the delivery of health care;151          (f)  providing employment supervision or adopting employment requirements that do152     not interfere with the licensee's ability to exercise independent professional judgment on behalf153     of the licensee's patients, provided that employment requirements that may not be considered to154     interfere with an employed licensee's exercise of independent professional judgment include:155          (i)  an employment requirement that restricts the licensee's access to patients with156     whom the licensee's employer does not have a contractual relationship, either directly or157     through contracts with one or more third-party payers; or158          (ii)  providing compensation incentives that are not related to the treatment of any159     particular patient;160          (g)  providing benefit coverage information, giving advice, or expressing opinions to a161     patient or to a family member of a patient to assist the patient or family member in making a162     decision about health care that has been recommended by a licensee; [or]163          (h)  in compliance with Section 58-85-103:164          (i)  obtaining an investigational drug or investigational device;165          (ii)  administering the investigational drug to an eligible patient; or166          (iii)  treating an eligible patient with the investigational drug or investigational device;167     or168          [(h)] (i)  any otherwise lawful conduct that does not substantially interfere with the169     licensee's ability to exercise independent professional judgment on behalf of the licensee's170     patients and that does not constitute the practice of medicine as defined in this chapter.171          Section 4.  Section 58-68-502 is amended to read:172          58-68-502. Unprofessional conduct.173          (1)  "Unprofessional conduct" includes, in addition to the definition in Section174     58-1-501:175          [(1)] (a)  using or employing the services of any individual to assist a licensee in any176     manner not in accordance with the generally recognized practices, standards, or ethics of the177     profession, state law, or division rule; or178          [(2)] (b)  violating the dispensing requirements of Section 58-17b-309 or Chapter 17b,179     Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy,180     if applicable.181          (2)  "Unprofessional conduct" does not include, in compliance with Section 58-85-103:182          (a)  obtaining an investigational drug or investigational device;183          (b)  administering the investigational drug to an eligible patient; or184          (c)  treating an eligible patient with the investigational drug or investigational device.185          Section 5.  Section 58-85-101 is enacted to read:186     CHAPTER 85.  UTAH RIGHT TO TRY ACT187          58-85-101. Title.188          This chapter is known as the "Utah Right to Try Act."189          Section 6.  Section 58-85-102 is enacted to read:190          58-85-102. Definitions.191          As used in this chapter:192          (1)  "Eligible patient" means an individual who has been diagnosed with a terminal193     illness by a physician.194          (2)  "Physician" means an individual who is licensed under:195          (a)  Title 58, Chapter 67, Utah Medical Practice Act; or196          (b)  Title 58, Chapter 68, Utah Osteopathic Medical Practice Act.197          (3)  "Insurer" means the same as that term is defined in Section 31A-1-301.198          (4)  "Investigational device" means a device that:199          (a)  meets the definition of "investigational device" in 21 C.F.R. Sec. 812.3; and200          (b)  has successfully completed the United States Food and Drug Administration Phase201     1 testing for an investigational device described in 21 C.F.R. Part 812.202          (5)  "Investigational drug" means a drug that:203          (a)  meets the definition of "investigational new drug" in 21 C.F.R. Sec. 312.3; and204          (b)  has successfully completed the United States Food and Drug Administration Phase205     1 testing for an investigational new drug described in 21 C.F.R. Part 312.206          (6)  "Terminal illness" means a condition of a patient that:207          (a)  is serious or life-threatening;208          (b)  as determined by a physician, is likely to pose a greater risk to the patient than the209     risk posed to the patient by treatment with an investigational drug or investigational device;210     and211          (c)  presents the patient with no treatment option that is satisfactory or comparable to212     treatment with an investigational drug or device.213          Section 7.  Section 58-85-103 is enacted to read:214          58-85-103. Right to request investigational drug or device.215          (1)  An eligible patient may obtain an investigational drug through an agreement with216     the investigational drug's manufacturer and the eligible patient's physician that provides:217          (a)  for the transfer of the investigational drug from the manufacturer to the physician;218     and219          (b)  that the physician will administer the investigational drug to the patient.220          (2)  An eligible patient may obtain an investigational device through an agreement with221     the investigational device's manufacturer and the eligible patient's physician that provides:222          (a)  for the transfer of the investigational device from the manufacturer to the physician;223     and224          (b)  that the physician will use the investigational device to treat the patient.225          Section 8.  Section 58-85-104 is enacted to read:226          58-85-104. Insurance coverage -- No right of action.227          This chapter does not:228          (1)  require an insurer to cover the cost of:229          (a)  administering an investigational drug under this chapter; or230          (b)  treating a patient with an investigational device under this chapter;231          (2)  prohibit an insurer from covering the cost of:232          (a)  administering an investigational drug under this chapter; or233          (b)  treating a patient with an investigational device under this chapter;234          (3)  require a manufacturer of an investigational drug or investigational device to agree235     to make an investigational drug or investigational device available to an eligible patient or an236     eligible patient's physician;237          (4)  require a physician to agree to:238          (a)  administer an investigational drug to an eligible patient under this chapter; or239          (b)  treat an eligible patient with an investigational device under this chapter; or240          (5)  create a private right of action for any harm done to an eligible patient:241          (a)  resulting from the eligible patient's use of an investigational drug or investigational242     device, against:243          (i)  a manufacturer of an investigational drug or investigational device under this244     chapter;245          (ii)  a physician who administers an investigational drug or treats an eligible patient246     with an investigational device under this chapter; or247          (iii)  a hospital where a physician administers an investigational drug to an eligible248     patient or treats an eligible patient with an investigational device under this chapter;249          (b)  against a physician or hospital, for the physician's or hospital's refusal to:250          (i)  administer an investigational drug to an eligible patient under this chapter; or251          (ii)  treat an eligible patient with an investigational device under this chapter; or252          (c)  against a manufacturer, for the manufacturer's refusal to provide an eligible patient253     with an investigational drug or an investigational device under this chapter.Legislative Review Note     as of   1-5-15  5:25 PMOffice of Legislative Research and General Counsel

